Prosight Management’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-12,112	Closed	-$1.5M	–	56
2020 Q4	$1.5M	Sell	12,112 -102,442	-89%	-$13.5M	0.75%	30
2020 Q3	$11.2M	Buy	114,554 +32,454	+40%	+$4.06M	5.51%	4
2020 Q2	$12.8M	Buy	82,100 +7,100	+9%	+$1.08M	6.36%	3
2020 Q1	$10.8M	Buy	75,000 +12,100	+19%	+$2.34M	5.09%	6
2019 Q4	$12.9M	Buy	62,900 +309	+0.5%	+$56.4K	5.88%	6
2019 Q3	$5.03M	Sell	62,591 -62,374	-50%	-$5.29M	2.8%	16
2019 Q2	$11.8M	Sell	124,965 -50,735	-29%	-$4.38M	5.99%	4
2019 Q1	$15M	Sell	175,700 -77,300	-31%	-$6.42M	6.89%	4
2018 Q4	$14.2M	Buy	253,000 +172,845	+216%	+$10.6M	7.33%	2
2018 Q3	$6.55M	Sell	80,155 -2,939	-4%	-$207K	3.71%	10
2018 Q2	$2.91M	Sell	83,094 -214,656	-72%	-$6.54M	2.13%	18
2018 Q1	$6.11M	Buy	297,750 +124,853	+72%	+$3.21M	3.98%	8
2017 Q4	$4.9M	Buy	+172,897	New	+$4.82M	3.65%	11